GCC Nurse Guide: Sickle Cell Disease

    Clinical Priority — Know Your Patient Population
    SCD is one of the most common severe genetic disorders in the GCC region. High prevalence, mandatory screening, and extreme heat-related dehydration make SCD a core competency for GCC nurses.
  

HbS Polymerisation — The Core Mechanism

        What triggers sickling?
        Deoxygenation causes HbS to polymerise into rigid fibres, distorting red cells into sickle shape. Sickled cells obstruct microvasculature, causing ischaemia and pain.
      

Trigger	Clinical Relevance in GCC
Dehydration	Most common GCC trigger — extreme heat (45–50°C summers), outdoor workers, Ramadan fasting
Hypoxia	Altitude, infection, pneumonia, post-operative, over-sedation
Acidosis	Infection, renal failure, DKA — worsens polymerisation
Cold	Air-conditioning exposure (common in GCC buildings), cold IV fluids
Infection / Fever	High risk due to autosplenectomy — encapsulated organisms
Physical/emotional stress	Surgery, trauma, anxiety, strenuous exertion

SCD Genotypes — Severity Spectrum

Genotype	Severity	Key Features
HbSS	Most Severe	Classic sickle cell anaemia; Hb 60–90 g/L; frequent crises
HbSC	Moderate	Higher Hb (~100 g/L); less frequent crises but retinopathy and avascular necrosis risk
HbS-β0 thalassaemia	Severe	Similar to HbSS — no normal Hb production
HbS-β+ thalassaemia	Moderate	Some HbA present; milder course
HbSS + high HbF	Milder	HbF inhibits polymerisation; fewer crises; target of hydroxyurea therapy
HbS trait (carrier)	Asymptomatic	Usually no crises; rarely sickling under extreme stress/hypoxia

GCC Prevalence & Screening Context

          GCC Carrier Rates (HbS trait)
          Saudi Arabia (Eastern Province): up to 25% carrier rate — highest in GCC
Bahrain: approximately 18% carrier rate
Kuwait: approximately 12–15% carrier rate
UAE & Oman: 8–12% carrier rate
Qatar: lower but significant rates in local populations

        

          Mandatory Premarital Screening
          Most GCC countries require premarital screening for haemoglobinopathies including HbS. Couples identified as double carriers are counselled regarding risks (25% chance SCD offspring). Awareness varies; nursing education is essential.
        

          Neonatal Screening
          Mandatory neonatal screening is established in Saudi Arabia, Bahrain, UAE, and Kuwait. Early diagnosis allows prophylactic penicillin and vaccination before autosplenectomy-related infections occur. Bahrain pioneered GCC neonatal SCD screening in the 1990s.
        

          GCC Climate & SCD — Nursing Alert
          Summer temperatures of 45–50°C create extreme dehydration risk. Patients must be counselled on hydration. Ramadan fasting (no fluid from dawn to sunset) is a specific annual high-risk period. Nurses must proactively identify fasting SCD patients.
        

Chronic Organ Damage — SCD Complications Overview

Organ / System	Complication	Pathophysiology
Spleen	Autosplenectomy by adolescence	Repeated infarcts destroy splenic tissue; loss of immune function against encapsulated organisms
Bones	Avascular necrosis (femoral/humeral head), dactylitis in infants	Vascular occlusion to bone marrow; chronic ischaemia
Brain	Stroke (11% by age 20), silent infarcts	Large vessel vasculopathy; high-velocity flow on TCD indicates risk
Kidneys	Sickle nephropathy, haematuria, hyposthenuria, CKD	Medullary ischaemia; inability to concentrate urine increases dehydration risk
Lungs	Acute chest syndrome, pulmonary hypertension	Repeated lung injury; progressive vascular remodelling
Eyes	Proliferative retinopathy (esp. HbSC)	Retinal vessel occlusion; neovascularisation; risk of blindness
Skin	Chronic leg ulcers (medial malleolus)	Microvascular occlusion and poor healing; chronic pain and infection risk
Liver	Sickle hepatopathy, gallstones (pigment)	Intrahepatic sickling; chronic haemolysis produces bilirubin stones early in life
Reproductive	Priapism (males), pregnancy complications	Vascular occlusion in erectile tissue; placental sickling increases obstetric risk

    Critical Nursing Principle — Never Undertreat SCD Pain
    Sickle cell pain is viscerally severe and consistently undertreated by clinical staff who may not appreciate its intensity. Pain scores should be taken at face value. Delays in analgesia worsen outcomes and risk ACS development.
  

VOC Triggers — Identify & Remove

Trigger	Nursing Action
Dehydration Most common GCC	IV/oral fluids immediately; assess intake/output; check skin turgor, mucous membranes
Infection / Fever	Blood cultures, urine MC&S, CXR; antibiotics per protocol; FBC, CRP
Cold environment	Warm blankets; room temperature check; avoid cold IV fluids; use warm compress on painful areas
Hypoxia	Pulse oximetry; SpO2 target ≥95%; treat underlying cause
Stress / exertion	Rest; calm environment; emotional support; anxiolytic if prescribed
Post-operative	Incentive spirometry; adequate hydration; avoid hypothermia; early mobilisation

Pain Assessment

        Use NRS or VAS every 30–60 minutes during acute VOC
        Sickle cell pain is neuropathic and ischaemic — it is among the most severe pain encountered in medicine. Staff may unconsciously downgrade scores. Document patient-reported pain without modification.
      

1–4

Mild

Oral analgesia; hydration; warmth

5–6

Moderate

Oral/IM opioid + regular NSAID

7–10

Severe

IV morphine; consider PCA

Reassess within 30 min of each analgesic dose. Escalate if NRS not reducing by ≥2 points.

Analgesia Protocol — WHO Ladder Applied to SCD

Pain Level	First-line Analgesia	Adjuncts	Notes
Mild (NRS 1–4)	Paracetamol 1g PO q6h + Ibuprofen 400mg PO q8h (if renal function adequate)	Oral hydration; warm compress; anxiolytic if needed	NSAIDs: avoid if creatinine elevated or active peptic disease
Moderate (NRS 5–6)	Tramadol 50–100mg PO/IV q6h OR Codeine 30–60mg PO q4–6h + continue paracetamol	Continue NSAID if tolerated; consider oral morphine	Codeine is a prodrug — slow metabolisers may have inadequate effect
Severe (NRS 7–10)	Morphine IV 0.05–0.1 mg/kg bolus q15–30min until NRS <7, then PCA or regular IV/SC dosing	Continue paracetamol regularly; consider ketorolac IV	Weight-based dosing; titrate to effect; do not wait for full washout before re-dosing if pain persists

Prescribe laxative with every opioid Antiemetic as needed (ondansetron) Avoid pethidine — norpethidine seizure risk Document NRS before and after every dose

IV Fluid Management

        Target: 1.5× maintenance rate — Not more
        Correct dehydration rapidly but do not over-hydrate. Excess fluid increases risk of pulmonary oedema and ACS. Use 0.9% NaCl or Hartmann's. Avoid hypotonic solutions.
      

Parameter	Target
Urine output	≥1 mL/kg/hr
Fluid rate	1.5× maintenance (approximately 2.5–3 L/24h adult)
Fluid type	0.9% NaCl (first line); Hartmann's acceptable
Monitoring	Fluid balance chart q4–6h; daily weight; check for oedema
Stop if	Respiratory symptoms develop — assess for ACS immediately

Oxygen & Supportive Measures

        Oxygen: Only if SpO2 <95%
        Do NOT give prophylactic oxygen to normoxic SCD patients. Excessive oxygen suppresses erythropoietin production and can worsen anaemia long-term.
      

Warmth: Warm blankets, heated room — cold causes vasoconstriction and worsens sickling
Position: Comfortable; elevate affected limbs to reduce oedema
Incentive spirometry: Every 2 hours when awake — prevents ACS from splinting
Rest: Minimise physical exertion during crisis
Emotional support: SCD patients often know their pain better than staff — validate and believe their pain
Laxatives: Co-prescribe with every opioid prescription (e.g. lactulose, senna)

VOC Nursing Assessment — Initial Presentation

1Rapid triage: NRS pain score, SpO2, HR, BP, RR, temperature — within 30 minutes of presentation
2IV access (large bore); blood samples: FBC, reticulocytes, U&E, LFTs, CRP, blood cultures if febrile
3First analgesic dose within 30 minutes of arrival — DO NOT delay pending investigations
4IV fluids commenced; oral fluids encouraged; fluid balance chart initiated
5CXR if any respiratory symptoms, SpO2 <95%, or fever >38.5°C (rule out ACS)
6Reassess NRS within 30 min of analgesia; escalate if inadequate response
7Incentive spirometry initiated; warm environment confirmed; triggers identified and addressed

    ACS — Leading Cause of Death in Sickle Cell Disease
    Acute Chest Syndrome can develop from VOC (fat embolism, in-situ thrombosis, infection) and progresses rapidly. Any SCD patient with chest symptoms must be assessed for ACS urgently.
  

ACS Diagnostic Criteria

        ACS = New pulmonary infiltrate on CXR + at least ONE of:
        Fever (>38.5°C)
Chest pain
Cough or dyspnoea
Hypoxia (SpO2 <95% or >3% drop from baseline)
Tachypnoea (RR >25/min in adults)

      

        Common Causes of ACS
        Fat embolism from bone marrow infarction
In-situ sickling in pulmonary microvasculature
Atypical infection: Mycoplasma pneumoniae, Chlamydia pneumoniae
Typical organisms: Streptococcus pneumoniae, Staphylococcus aureus
Splinting from pain → hypoventilation → atelectasis

      

ACS — Immediate Nursing Actions

1CALL DOCTOR IMMEDIATELY — ACS is a medical emergency
2Oxygen: target SpO2 ≥95% — start O2 via nasal cannula/face mask; escalate to HFNO if needed
3Analgesia: adequate pain relief reduces splinting — use IV morphine but monitor respiratory rate; avoid over-sedation
4Antibiotics: azithromycin 500mg IV/PO (atypical cover) + ceftriaxone 2g IV (typical cover) — give within 1 hour
5CXR (may be normal initially — repeat in 12–24h if ACS suspected clinically)
6Bronchodilators: salbutamol nebuliser if wheeze or bronchospasm present
7Incentive spirometry: every 2 hours — critical to prevent progression
8Prepare for exchange transfusion if severe hypoxia, rapid deterioration, or bilateral infiltrates

Exchange Transfusion — Nursing Role

          Indications for Exchange Transfusion in ACS
          SpO2 <90% despite supplemental oxygen
Rapid deterioration or bilateral infiltrates
Mechanical ventilation or pending intubation
Hb drop >20 g/L from baseline
Target: reduce HbS% to <30%

        

          Simple Transfusion vs Exchange
          Simple top-up transfusion risks hyperviscosity (Hb rises but HbS% unchanged). Exchange transfusion replaces sickle cells with donor HbA cells — reduces HbS burden safely. Preferred for severe ACS.
        

          Nursing Preparation — Exchange Transfusion
          Large-bore IV access x2 or central venous access
Cross-match and group and screen — extended phenotyping for SCD patients
Baseline: Hb, HbS%, FBC, U&E, LFTs, coagulation
Blood volume calculation: 70 mL/kg (adult); target 2–3 blood volumes exchanged
Monitor: HR, BP, SpO2 continuously; fluid balance; hypocalcaemia (from citrate in blood)
Post-procedure: repeat FBC and HbS% — confirm <30%

        

Respiratory Support Options

Modality	When	Nursing Notes
Nasal cannula 2–4 L/min	SpO2 90–94%	Well-tolerated; check nares for drying
Simple face mask 5–10 L/min	SpO2 <92%; moderate hypoxia	Ensure tight seal; watch for CO2 retention
HFNO (Optiflow)	SpO2 persistently <90%; increasing work of breathing	Start at 30–40 L/min; titrate FiO2; humidification important
CPAP	Hypoxaemia not responding to HFNO	Avoid aggressive positive pressure — risk of pneumothorax; call ICU early
Mechanical ventilation	Impending respiratory failure	ICU referral; lung-protective ventilation; exchange transfusion mandatory

ACS Prevention in All Hospitalised SCD Patients

        Incentive Spirometry — Mandatory for All Admitted SCD Patients
        Pain causes splinting (shallow breathing) which leads to atelectasis and ACS. All admitted SCD patients should perform incentive spirometry every 2 hours while awake, regardless of reason for admission.
      

Demonstrate correct technique on admission; repeat education daily
Document compliance on nursing chart
Adequate analgesia must precede spirometry — pain prevents effective deep breathing
Mobilise patient when safe — reduces ACS risk
Monitor SpO2 trend — early warning of ACS development

Splenic Sequestration Crisis

        Emergency — Mainly in infants and young children before autosplenectomy
        Sudden massive trapping of RBCs in spleen causes acute severe anaemia and hypovolaemic shock. Splenomegaly rapidly enlarges. Can be fatal within hours.
      

Feature	Detail
Signs	Sudden pallor, lethargy, tachycardia, abdominal distension, rapidly enlarging spleen
Hb drop	≥20 g/L drop from baseline; severe anaemia (may be <40 g/L)
Immediate action	IV access; urgent blood transfusion; fluid resuscitation
Transfusion target	Hb to ~70 g/L initially — do not over-transfuse (auto-correction occurs)
Definitive treatment	Splenectomy after stabilisation (recurrence rate high)
Parent education	Teach spleen palpation at home — early detection saves lives

Stroke in SCD

        11% incidence by age 20 — Leading cause of childhood disability in SCD
        SCD stroke is mainly ischaemic (large vessel vasculopathy) in children; haemorrhagic strokes occur in adults. Exchange transfusion is the preferred acute intervention.
      

Aspect	Detail
Presentation	Sudden hemiplegia, facial droop, speech difficulty, seizure, altered consciousness
Nursing: NIHSS	Document NIHSS score; monitor neurological status hourly
Thrombolysis (tPA)	Controversial — not standard in SCD; exchange transfusion preferred
Exchange transfusion	Urgent — target HbS <30%; call haematology immediately
Prevention	TCD screening annual; chronic transfusion programme if high velocity
Secondary prevention	Long-term monthly transfusion programme; consider hydroxyurea

Priapism

        Painful erection lasting >4 hours — Urological emergency
        Low-flow (ischaemic) priapism due to sickling in cavernous sinusoids. Risk of permanent erectile dysfunction if untreated >4–6 hours.
      

1Adequate hydration (IV fluids) and analgesia immediately
2Warm bath or warm compress to perineum — vasodilation
3Urological referral immediately — corpus cavernosum aspiration + phenylephrine irrigation (>4 hours)
4Exchange transfusion for refractory priapism or recurrent episodes
5Document onset time clearly — duration determines urgency and prognosis
6Counselling: avoid shame barriers to seeking help early; regular SCD follow-up

Do NOT use ice or cold — worsens sickling Etilefrine self-injection: home management option in recurrent cases

Aplastic Crisis

        Parvovirus B19 infection — Temporary marrow suppression
        Parvovirus B19 infects erythroid progenitors, halting red cell production for 7–10 days. In SCD (short RBC lifespan of 20 days), this causes rapid, severe anaemia.
      

Feature	Detail
Reticulocytes	Markedly low or absent (<0.5%) — key diagnostic feature
Hb trend	Rapidly falling; may reach <40 g/L
Treatment	Red cell transfusion; supportive care; self-limiting in 7–14 days
Infection control	Isolate patient — parvovirus B19 is infectious to immunocompromised patients and pregnant contacts
Family screening	Siblings with SCD may develop aplastic crisis simultaneously

Sepsis in SCD — Functional Asplenia

        Any fever in SCD patient = medical emergency until proven otherwise
        Autosplenectomy removes the primary filter for encapsulated organisms. Overwhelming post-splenectomy infection (OPSI) can cause death within hours.
      

Organism	Risk	Management
Streptococcus pneumoniae	Highest risk	Ceftriaxone 50 mg/kg IV (max 2g) immediately; blood cultures first if possible
Haemophilus influenzae	High risk	Covered by ceftriaxone; ensure Hib vaccination
Neisseria meningitidis	High risk	Covered by ceftriaxone; meningococcal vaccination essential
Salmonella spp.	Moderate	Bone/joint infections common in SCD; ciprofloxacin or ceftriaxone

        Nursing Rule: Antibiotics within 1 hour of fever in any SCD patient
        Do not wait for culture results. Take blood cultures simultaneously, then give antibiotics immediately.
      

Acute Sickle Hepatopathy

        Intrahepatic sickling causing hepatic ischaemia and dysfunction
        Severe right upper quadrant pain, jaundice, rapidly rising bilirubin and LFTs, coagulopathy. Can progress to acute liver failure.
      

Presentation: RUQ pain, fever, jaundice, nausea; LFTs markedly elevated
Management: Exchange transfusion reduces HbS burden; supportive hepatic care
Monitor: PT/INR, bilirubin, ALT trend, fluid balance, encephalopathy signs
Gallstones: Chronic haemolysis creates pigment stones — can cause biliary colic or cholecystitis
Differentiate from: Viral hepatitis, right-sided ACS, biliary obstruction
Nursing: Strict fluid balance; avoid hepatotoxic drugs (paracetamol max dose caution in hepatic failure); HADS scoring for cholestasis symptoms

Hydroxyurea (Hydroxycarbamide)

        Mechanism: Increases HbF production — reduces sickling polymerisation
        HbF dilutes HbS in cells, inhibiting polymerisation. Also reduces WBC adhesion and improves RBC hydration.
      

Parameter	Detail
Indication	≥3 painful crises/year; ACS; stroke prevention; symptomatic SCD
Starting dose	15 mg/kg/day PO; titrate to 25–35 mg/kg/day (max tolerated)
Response indicator	Rise in MCV and HbF level; reduced crisis frequency
FBC monitoring	Every 4 weeks during dose escalation; every 3 months when stable
Hold if neutrophils	<2.0 × 10&sup9;/L — withhold; restart at lower dose when recovered
Hold if platelets	<80 × 10&sup9;/L — withhold; restart when recovered
Hold if Hb drop	>20 g/L from baseline — assess for aplastic crisis
Teratogenicity	Category D — contraindicated in pregnancy; counsel all reproductive-age patients

Wear gloves when handling tablets (cytotoxic) Effective contraception required in childbearing age Effects seen in 3–6 months

Transcranial Doppler (TCD) Screening

        Annual TCD screening from age 2–16 years in all HbSS and HbS-β0 patients
        Elevated blood velocity in cerebral arteries indicates stenosis and stroke risk. TCD identifies patients who benefit from chronic transfusion programme.
      

TCD Velocity (TAMMV)	Interpretation	Action
<170 cm/s	Normal	Repeat annually
170–199 cm/s	Conditional	Repeat in 3–6 months; optimise hydroxyurea
≥200 cm/s	Abnormal	Start chronic transfusion programme; haematology referral urgent

Nursing: explain procedure to child and parent; no sedation required; document velocity and compare to previous readings.

Vaccinations & Prophylactic Penicillin

Vaccine	Schedule	Priority
Pneumococcal (PCV13 + PPSV23)	PCV13 in infancy; PPSV23 at 2 & 5 years; boosters per guidelines	Highest
Hib	Routine childhood schedule	Highest
Meningococcal (ACWY + B)	Primary series + boosters	Highest
Hepatitis B	Complete series — transfusion exposure risk	High
Influenza	Annual	High
COVID-19	Per national schedule	High

          Prophylactic Penicillin
          Start at diagnosis (ideally by 2–3 months of age)
Penicillin V 125mg PO BD (under 5 years); 250mg PO BD (over 5 years)
Continue until at least age 5; many guidelines continue lifelong in HbSS
Penicillin allergy: erythromycin substitute
Nursing: education to parents — never miss a dose; seek medical help for any fever

        

Chronic Transfusion & Iron Overload

        Iron overload is inevitable with chronic transfusion — monitoring and chelation essential
        Each unit of blood delivers ~200–250 mg iron. The body has no mechanism to excrete excess iron. Iron deposits in heart, liver, and endocrine organs causing organ failure.
      

Parameter	Target / Threshold
Serum ferritin monitoring	Every 3 months; target <1000 mcg/L with chronic transfusion
Liver MRI (T2*)	Annual if ferritin >1000 mcg/L or >1 year of regular transfusion
Cardiac MRI T2*	Annual if ferritin >2500 mcg/L or cardiac symptoms
Desferrioxamine (SC/IV)	5–50 mg/kg/day SC infusion 8–12h, 5–7 nights/week
Deferasirox (oral)	20–40 mg/kg/day OD; monitor renal function and LFTs monthly

Nursing: teach subcutaneous pump technique for desferrioxamine; rotate injection sites; monitor for local reactions.

Hydration & GCC-Specific Education

        Daily fluid target: 2.5–3 L/day for adults
        SCD kidneys cannot concentrate urine adequately (hyposthenuria) — patients lose more fluid in urine than normal individuals. In GCC summer, insensible losses are extreme.
      

Carry water at all times; set phone reminders to drink
Avoid outdoor activities between 11am–4pm in GCC summer
Prefer air-conditioned environments but avoid cold drafts (vasoconstriction risk)
Urine colour chart: aim for pale yellow urine throughout the day

        Ramadan Fasting in SCD — High-Risk Period
        No oral fluids from Fajr to Maghrib — typically 13–16 hours in GCC summer
Islamic scholars permit exemption from fasting for medical conditions (SCD qualifies)
Nurses should proactively discuss Ramadan plan at every clinic visit
If patient chooses to fast: pre-dawn hydration strategy, break fast at first crisis sign, hospital number clearly given
Hydroxyurea dose timing: take at Iftar with water

      

ACS Diagnostic Criteria — Exam Format

      ACS = New pulmonary infiltrate on imaging + ≥1 of: fever, chest pain, cough/dyspnoea, hypoxia (SpO2 <95%)
    

ACS Severity	Features	Management Key Points
Mild	SpO2 ≥95% on air, single lobe, responsive to O2	O2, analgesia, antibiotics, incentive spirometry, monitor closely
Moderate	SpO2 90–95%, bilateral/multilobar, not improving	O2 (HFNO), IV antibiotics, exchange transfusion discussion, escalate analgesia
Severe	SpO2 <90%, intubation risk, bilateral infiltrates, rapid deterioration	URGENT exchange transfusion (HbS <30%), ICU referral, mechanical ventilation readiness

VOC Pain Escalation — Exam Algorithm

Step	Pain Score	Action	Time Target
1	Any — on arrival	Assess NRS, vital signs, SpO2; IV access; blood tests	Within 30 min
2	NRS 1–4	Oral paracetamol + ibuprofen; oral fluids; warm environment	Within 30 min
3	NRS 5–6	Add oral/IV tramadol or codeine; reassess in 30 min	Within 30 min
4	NRS 7–10 or not responding	IV morphine 0.05–0.1 mg/kg; consider PCA; anti-emetic; laxative	Within 60 min of arrival
5	Reassessment	Reassess NRS 30 min after each dose; escalate if <2 point reduction	Every 30 min

SCD Complications — Organ by Organ Reference Table

Organ	Complication	Nursing/Clinical Key Point
Spleen	Autosplenectomy, sequestration	Sequestration: children; urgent transfusion; teach spleen palpation to parents
Brain	Stroke, silent infarcts	11% by age 20; TCD screening; exchange transfusion for acute stroke; chronic transfusion for prevention
Lungs	ACS, pulmonary hypertension	ACS = leading cause of death; incentive spirometry prevents it; TRV >2.5 m/s: PHT screening
Kidneys	Hyposthenuria, nephropathy, haematuria	Cannot concentrate urine — always dehydrated; monitor creatinine; avoid NSAIDs with renal impairment
Bones	AVN femoral head, dactylitis	AVN: orthopedics referral; dactylitis in infants — first sign of SCD often
Eyes	Proliferative retinopathy	Annual ophthalmology review; HbSC has higher retinopathy rate than HbSS
Liver	Sickle hepatopathy, gallstones	Pigment gallstones from chronic haemolysis; cholecystectomy common in SCD
Genitalia	Priapism	>4 hours: aspirate + phenylephrine; >6 hours: permanent dysfunction risk; no cold
Skin	Leg ulcers	Medial malleolus; chronic; moist dressings; refer to wound care; avoid trauma
Immune	Functional asplenia, sepsis	Any fever = antibiotics within 1 hour; prophylactic penicillin + vaccinations

Hydroxyurea Monitoring — Quick Reference

Parameter	Action Threshold
Neutrophils	Hold if <2.0 × 10&sup9;/L
Platelets	Hold if <80 × 10&sup9;/L
Hb drop	Hold if >20 g/L below baseline
MCV rise	Expected — marker of compliance and response
HbF rise	Target ≥20% — indicates therapeutic response
Frequency	4-weekly during escalation; 3-monthly when stable
Contraindication	Pregnancy; planning pregnancy — use contraception

DHA / DOH / SCFHS / QCHP High-Yield SCD Questions

Q: Most common cause of death in SCD? ▼

A: Acute Chest Syndrome (ACS) — new pulmonary infiltrate + chest symptoms. Prevention: incentive spirometry, adequate analgesia, avoid over-sedation.

Q: Most common VOC trigger in GCC? ▼

A: Dehydration — GCC extreme heat (45–50°C), Ramadan fasting, outdoor work. Target 2.5–3 L fluid/day. Hyposthenuria means SCD kidneys cannot concentrate urine.

Q: Why avoid oxygen in normoxic SCD patients? ▼

A: Oxygen only if SpO2 <95%. Excessive O2 suppresses erythropoietin (EPO) production, worsening anaemia long-term. No prophylactic oxygen.

Q: Hydroxyurea mechanism in SCD? ▼

A: Increases HbF (fetal haemoglobin) production. HbF inhibits HbS polymerisation, reducing sickling. Also reduces WBC count and adhesion. Monitor: FBC every 4 weeks during escalation.

Q: TCD velocity indicating stroke risk? ▼

A: TAMMV ≥200 cm/s = abnormal — start chronic transfusion programme. 170–199 cm/s = conditional — repeat in 3–6 months. Annual TCD from age 2–16 in HbSS.

Q: Target HbS% after exchange transfusion? ▼

A: HbS <30% — for acute stroke, severe ACS, refractory priapism. Exchange (not simple) transfusion avoids hyperviscosity. Confirm with post-procedure HbS% level.

Q: Aplastic crisis — cause and key lab finding? ▼

A: Parvovirus B19 infects erythroid progenitors. Key finding: absent/very low reticulocytes (<0.5%) with falling Hb. Self-limiting in 7–14 days. Isolate patient — infectious to immunocompromised.

Q: Prophylactic penicillin — when to start and why? ▼

A: Start by 2–3 months of age. Autosplenectomy begins in infancy — prophylaxis protects against encapsulated organisms (S. pneumoniae, H. influenzae, N. meningitidis). Continue to at least age 5 (many lifelong in HbSS).

SCD Crisis Severity & Management Guide

Enter current clinical parameters to receive a severity assessment and recommended management pathway.

Clinical Assessment Tool

Pain Score (NRS 0–10)

Temperature (°C)

SpO2 (%)

Current Hb vs Baseline (g/L)

Respiratory Symptoms? (cough / dyspnoea / chest pain)

New CXR Infiltrate?

Crisis Type

Sickle Cell Disease Nursing

Clinical Assessment Tool